Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04538417 · ClinicalTrials.gov registry record · NA

C-RFA of Residual Limb Neuroma

A NA study of Phantom Limb Pain and Neuroma Amputation, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT04538417 is a NA study of Phantom Limb Pain and Neuroma Amputation that has completed, run by University of Utah. The registered enrollment target is 8 participants, below the 122-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04538417, a NA study of Phantom Limb Pain and Neuroma Amputation, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

To assess changes in pain, physical function, and health-related quality of life in patients with post-amputation neuroma-associated residual limb pain after cooled radiofrequency ablation.

Interventions

  • DEVICE Cooled Radiofrequency Ablation

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2019-10-27
Est. Completion 2023-08-30
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT04538417

The ClinicalTrials.gov registry entry for NCT04538417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 122-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (93% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Phantom Limb Pain appearing as the primary indexed condition, and to 1 intervention - of which Cooled Radiofrequency Ablation is the first listed.

NCT04538417 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT04538417 about?

NCT04538417 is a clinical study titled "C-RFA of Residual Limb Neuroma". To assess changes in pain, physical function, and health-related quality of life in patients with post-amputation neuroma-associated residual limb pain after cooled radiofrequency ablation.

What is the current status of trial NCT04538417?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2019-10-27. Estimated completion is 2023-08-30.

What conditions does trial NCT04538417 study?

This clinical trial studies the following conditions: Phantom Limb Pain, Neuroma Amputation.

What interventions are being tested in trial NCT04538417?

The interventions under investigation include: Cooled Radiofrequency Ablation (DEVICE).

Who is sponsoring clinical trial NCT04538417?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04538417 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Phantom Limb Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.